ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $203,718,000 | +46.8% | 1,183,716 | +7.0% | 0.01% | +57.1% |
| Q2 2021 | $138,776,000 | +2.6% | 1,105,870 | +10.9% | 0.01% | -12.5% |
| Q1 2021 | $135,194,000 | -7.1% | 996,933 | -12.4% | 0.01% | -11.1% |
| Q4 2020 | $145,572,000 | +12.8% | 1,137,811 | -0.8% | 0.01% | 0.0% |
| Q3 2020 | $129,089,000 | +20.0% | 1,147,151 | +1.6% | 0.01% | +12.5% |
| Q2 2020 | $107,560,000 | -19.0% | 1,129,003 | -23.6% | 0.01% | -33.3% |
| Q1 2020 | $132,731,000 | +71.2% | 1,476,926 | +1.0% | 0.01% | +140.0% |
| Q4 2019 | $77,516,000 | +37.8% | 1,462,016 | +2.7% | 0.01% | +25.0% |
| Q3 2019 | $56,245,000 | -11.5% | 1,423,552 | -7.9% | 0.00% | -20.0% |
| Q2 2019 | $63,519,000 | -25.9% | 1,546,223 | -16.0% | 0.01% | -28.6% |
| Q1 2019 | $85,713,000 | +34.4% | 1,840,515 | +25.7% | 0.01% | +16.7% |
| Q4 2018 | $63,765,000 | -28.0% | 1,464,181 | -5.4% | 0.01% | -14.3% |
| Q3 2018 | $88,579,000 | +19.0% | 1,547,795 | +0.9% | 0.01% | +16.7% |
| Q2 2018 | $74,416,000 | +29.9% | 1,533,710 | +4.7% | 0.01% | +20.0% |
| Q1 2018 | $57,283,000 | +1.4% | 1,464,989 | +10.0% | 0.01% | 0.0% |
| Q4 2017 | $56,510,000 | +36.3% | 1,331,509 | +19.8% | 0.01% | +25.0% |
| Q3 2017 | $41,465,000 | +20.6% | 1,111,051 | -1.8% | 0.00% | +33.3% |
| Q2 2017 | $34,386,000 | +25.5% | 1,131,824 | +9.4% | 0.00% | +50.0% |
| Q1 2017 | $27,395,000 | +13.8% | 1,034,625 | +9.7% | 0.00% | 0.0% |
| Q4 2016 | $24,071,000 | -25.0% | 943,174 | +6.3% | 0.00% | -33.3% |
| Q3 2016 | $32,098,000 | +27.6% | 886,955 | +19.8% | 0.00% | 0.0% |
| Q2 2016 | $25,163,000 | +11.8% | 740,403 | -13.2% | 0.00% | +50.0% |
| Q1 2016 | $22,514,000 | -10.6% | 853,062 | +65.1% | 0.00% | -33.3% |
| Q4 2015 | $25,196,000 | +202.3% | 516,603 | +54.3% | 0.00% | +200.0% |
| Q3 2015 | $8,335,000 | -7.1% | 334,854 | +18.1% | 0.00% | 0.0% |
| Q2 2015 | $8,973,000 | -4.0% | 283,638 | +15.6% | 0.00% | 0.0% |
| Q1 2015 | $9,343,000 | +2.4% | 245,460 | +4.8% | 0.00% | 0.0% |
| Q4 2014 | $9,128,000 | +40.3% | 234,277 | +8.9% | 0.00% | 0.0% |
| Q3 2014 | $6,507,000 | -65.3% | 215,192 | -61.0% | 0.00% | -50.0% |
| Q2 2014 | $18,769,000 | +406.6% | 552,445 | +414.0% | 0.00% | – |
| Q1 2014 | $3,705,000 | +3.3% | 107,479 | +18.7% | 0.00% | – |
| Q4 2013 | $3,586,000 | – | 90,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |